|
1
|
Marumoto T and Saya H: Molecular biology
of glioma. Adv Exp Med Biol. 746:2–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohgaki H, Dessen P, Jourde B, Horstmann S,
Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM,
Maiorka PC, et al: Genetic pathways to glioblastoma: A
population-based study. Cancer Res. 64:6892–6899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hervey-Jumper SL and Berger MS: Maximizing
safe resection of low- and high-grade glioma. J Neurooncol.
130:269–282. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ostrom QT, Gittleman H, Liao P, Rouse C,
Chen Y, Dowling J, Wolinsky Y, Kruchko C and Barnholtz-Sloan J:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2007–2011. Neuro Oncol.
16:(Suppl 4). iv1–iv63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thomas AA, Brennan CW, DeAngelis LM and
Omuro AM: Emerging therapies for glioblastoma. JAMA Neurol.
71:1437–1444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Husmann K, Arlt MJ, Muff R, Langsam B,
Bertz J, Born W and Fuchs B: Matrix Metalloproteinase 1 promotes
tumor formation and lung metastasis in an intratibial injection
osteosarcoma mouse model. Biochim Biophys Acta. 1832:347–354. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Korpi JT, Hagström J, Lehtonen N,
Parkkinen J, Sorsa T, Salo T and Laitinen M: Expression of matrix
metalloproteinases-2, −8, −13, −26, and tissue inhibitors of
metalloproteinase-1 in human osteosarcoma. Surg Oncol. 20:e18–e22.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deraz EM, Kudo Y, Yoshida M, Obayashi M,
Tsunematsu T, Tani H, Siriwardena SB, Keikhaee MR, Qi G, Iizuka S,
et al: MMP-10/stromelysin-2 promotes invasion of head and neck
cancer. PLoS One. 6:e254382011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Folgueras AR, Pendás AM, Sánchez LM and
López-Otin C: Matrix metalloproteinases in cancer: From new
functions to improved inhibition strategies. Int J Dev Biol.
48:411–424. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Overall CM and Kleifeld O: Tumour
microenvironment-opinion: Validating matrix metalloproteinases as
drug targets and anti-targets for cancer therapy. Nat Rev Cancer.
6:227–239. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Howald C, Merla G, Digilio MC, Amenta S,
Lyle R, Deutsch S, Choudhury U, Bottani A, Antonarakis SE, Fryssira
H, et al: Two high throughput technologies to detect segmental
aneuploidies identify new Williams-Beuren syndrome patients with
atypical deletions. J Med Genet. 43:266–273. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Micale L, Augello B, Fusco C, Selicorni A,
Loviglio MN, Silengo MC, Reymond A, Gumiero B, Zucchetti F,
D'Addetta EV, et al: Mutation spectrum of MLL2 in a cohort of
Kabuki syndrome patients. Orphanet J Rare Dis. 6:382011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liotta LA, Tryggvason K, Garbisa S, Hart
I, Foltz CM and Shafie S: Metastatic potential correlates with
enzymatic degradation of basement membrane collagen. Nature.
284:67–68. 1980. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stetler-Stevenson WG: Type IV collagenases
in tumor invasion and metastasis. Cancer Metastasis Rev. 9:289–303.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang QW, Liu L, Chen R, Wei YQ, Li P, Shi
HS and Zhao YW: Matrix metalloproteinase-9 as a prognostic factor
in gastric cancer: A meta-analysis. Asian Pac J Cancer Prev.
13:2903–2908. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song J, Su H, Zhou YY and Guo LL:
Prognostic value of matrix metalloproteinase 9 expression in breast
cancer patients: A meta-analysis. Asian Pac J Cancer Prev.
14:1615–1621. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng WJ, Zhang JQ, Wang BX, Pan HF, Lu MM
and Wang J: Prognostic value of matrix metalloproteinase 9
expression in patients with non-small cell lung cancer. Clin Chim
Acta. 413:1121–1126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li CY, Yuan P, Lin SS, Song CF, Guan WY,
Yuan L, Lai RB, Gao Y and Wang Y: Matrix metalloproteinase 9
expression and prognosis in colorectal cancer: A meta-analysis.
Tumour Biol. 34:735–741. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Micale L, Fusco C, Fontana A, Barbano R,
Augello B, De Nittis P, Copetti M, Pellico MT, Mandriani B,
Cocciadiferro D, et al: TRIM8 downregulation in glioma affects cell
proliferation and it is associated with patients survival. BMC
Cancer. 15:4702015. View Article : Google Scholar : PubMed/NCBI
|
